Overview

Study to Evaluate the Safety and Efficacy of Extended Release Tacrolimus (Advagraf®) + Sirolimus (Rapamune®), Versus Extended Release Tacrolimus (Advagraf®) + Mycophenolate Mofetil in Kidney Transplant Patients

Status:
Completed

Trial end date:
2016-01-01

Target enrollment:

Participant gender:

Summary

This study will compare the efficacy and safety of Extended Release Tacrolimus (Advagraf®) + Sirolimus (Rapamune®), versus Extended Release Tacrolimus (Advagraf®) + Mycophenolate mofetil in Kidney Transplant Patients.

Phase:

Phase 4

Details

Lead Sponsor:

Yonsei University

Treatments:

Everolimus
Mycophenolate mofetil
Mycophenolic Acid
Sirolimus
Tacrolimus